What to expect from different drugs used in the treatment of COVID-19: A study on applications and in vivo and in vitro results

Eur J Pharmacol. 2020 Nov 15:887:173467. doi: 10.1016/j.ejphar.2020.173467. Epub 2020 Aug 8.


The end of 2019 was marked by the emergence of a new type of coronavirus (SARS-CoV-2), which has killed more than 240,000 people around the world so far. Several clinical studies are being performed to test possible drugs in response to the COVID-19 outbreak; however, there is still no treatment that is completely effective. Our goal in this paper is to bring together the results of main studies carried out with different drugs in order to help spread the knowledge about possible treatments for COVID-19 that have been suggested so far.

Keywords: Anticoagulants; Antivirals; Chloroquine; Dexamethasone; Ivermectin.

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Antimalarials / therapeutic use
  • Antiviral Agents / therapeutic use*
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy*
  • Dexamethasone / therapeutic use
  • Humans
  • In Vitro Techniques
  • Pandemics
  • Pneumonia, Viral / drug therapy*


  • Anti-Inflammatory Agents
  • Antimalarials
  • Antiviral Agents
  • Dexamethasone